Skip to main navigation Skip to search Skip to main content

Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial

  • A. Hirsch
  • , R. Nijveldt
  • , P.A. van der Vleuten
  • , J.G. Tijssen
  • , W.J. van der Giessen
  • , R.A. Tio
  • , J. Waltenberger
  • , J.M. ten Berg
  • , P.A.F.M. Doevendans
  • , W.R. Aengevaeren
  • , J.J. Zwaginga
  • , B.J. Biemond
  • , A.C. van Rossum
  • , J.J. Piek
  • , x HEBE Investigators
  • , F. Zijlstra

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1736-47
Number of pages12
JournalEuropean Heart Journal
Volume32
Issue number14
DOIs
Publication statusPublished - 2011

Cite this